Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2007
07/12/2007US20070161792 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
07/12/2007US20070161651 Tie-2 modulators and methods of use
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070161637 Substituted pyridin-2-ylamine analogues
07/12/2007US20070161622 Diamino alcohols and their use as renin inhibitor
07/12/2007CA2635580A1 Substituted bis-amide metalloprotease inhibitors
07/11/2007EP1805155A1 Thrombopoietin activity modulating compounds and methods
07/11/2007EP1805148A2 Crystalline rosuvastatin intermediate
07/11/2007CN1997643A Heterocyclic compounds and their use as aldosterone synthase inhibitors
07/11/2007CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
07/11/2007CN1997622A Polycationic compounds and uses thereof
07/11/2007CN1997619A Phenyl derivatives comprising an acetylene group
07/11/2007CN1995022A Process for the synthesis of nucleoside analogues
07/11/2007CN1325480C Novel phenylalanine derivatives
07/11/2007CN1325479C Pyrimidine compounds
07/11/2007CN1325456C Perfluoroallyloxy compound and liquid-crystal composition containing the compound
07/10/2007US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents
07/10/2007US7241883 Functionalized compositions for improved immobilization
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/10/2007US7241769 Pyrimidines as PLK inhibitors
07/10/2007US7241767 And thiones, 1-substituted with a pyrazolyl(thio)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops
07/10/2007US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity
07/10/2007US7241458 Antiviral compositions
07/05/2007WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
07/05/2007WO2007076092A2 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
07/05/2007WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
07/05/2007WO2007074789A1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
07/05/2007WO2007074391A2 Preparation of a key intermediate in the synthesis of rosuvastatin
07/05/2007WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
07/05/2007WO2007043094A3 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
07/05/2007US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay
07/05/2007US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS
07/05/2007US20070155777 Antiinflammation agents
07/05/2007US20070155765 Method of preparation of the hemi-calcium salt of (e)-7-[4-(4fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonvl)aminolpyrimidin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acid
07/05/2007US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto
07/05/2007US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
07/05/2007US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
07/05/2007US20070155757 Use of pyrimidine compounds in the preparation of parasiticides
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155748 N-sulfonyl-alpha-amino-acid derivatives
07/05/2007US20070155719 Platelet ADP receptor inhibitors
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007US20070154972 immunogens, monoclonal antibodies which bind selectively to 5-fluoro-uracil and have cross-reactivity with uracil, cytosine and tegafur; for rapidly determining optimal drug concentrations during chemotherapy
07/05/2007CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
07/05/2007CA2634768A1 3-aryl-substituted quinazolones, and uses thereof
07/05/2007CA2633992A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
07/05/2007CA2633653A1 Heterocyclic derivatives as modulators of ion channels
07/04/2007EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring
07/04/2007EP1802591A1 Quinazoline derivatives
07/04/2007EP1802590A1 Substituted n-alkylpyrimidinones
07/04/2007EP1802589A1 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide
07/04/2007EP1802588A1 Substituted amino-pyrimidones and uses thereof
07/04/2007EP1802587A1 Substituted amino-compounds and uses thereof
07/04/2007EP1802586A2 Heteroaryl-substituted alkyne compounds and method of use
07/04/2007EP1644343B1 5-substituted quinazolinone derivatives
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP0977750B1 Farnesyltransferase inhibiting quinazolinones
07/04/2007CN1993356A Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
07/04/2007CN1990477A Linear dicationic terphenyls and their aza analogues as antiparasitic agents
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1989969A Cyclic protein tyrosine kinase inhibitors
07/04/2007CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics
07/04/2007CN1324030C Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances
07/04/2007CN1324015C Pyridine and pyrimidine derivatives
07/03/2007US7238807 Hydrogenating a nitropyrimidine derivative with hydrogen in the presence of a hydrogenation catalyst, adding a copper, iron or vanadium compound to produce 7,8-dihydro-5H-pteridin-6-one derivatives
07/03/2007US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007US7238702 Dihydroquinazolinones as 5HT modulators
07/03/2007US7238701 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
07/03/2007US7238698 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis.
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
07/03/2007CA2397258C Preparation of sulfonamides
06/2007
06/28/2007WO2007073284A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES
06/28/2007WO2007073117A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
06/28/2007WO2007071963A2 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
06/28/2007WO2007071900A1 Novel herbicides
06/28/2007WO2007071752A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
06/28/2007WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007071199A1 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof
06/28/2007WO2007071055A1 Compositions and methods for modulating gated ion channels
06/28/2007WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators
06/28/2007WO2007041666B1 Preparation of rosuvastatin
06/28/2007WO2007026920A3 Amide derivatives as rock inhibitors
06/28/2007WO2007016355A3 Process for the synthesis of progesterone receptor modulators
06/28/2007US20070149779 Primidone process and compositions
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149551 crop protection agents for controlling harmful fungi; improved activity; [6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-tri-fluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber
06/28/2007US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents
06/28/2007US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof
06/28/2007US20070149500 Compounds, compositions, and methods
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007DE102005062742A1 Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel Sulfoximine substituted pyrimidines, process for their preparation and their use as medicaments
06/28/2007DE102005062175A1 Detergent- or cleaning agent, useful e.g. in liquid or gel form for flushing toilets and hard surface cleaning, comprises cyclic aminal
06/28/2007CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/28/2007CA2634491A1 Compositions and methods for modulating gated ion channels
06/28/2007CA2634047A1 Pyrimidinyl aryl urea derivatives being fgf inhibitors